Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000068.xml
Download PDF
Semin intervent Radiol 2002; 19(1): 073-088
DOI: 10.1055/s-2002-25141
DOI: 10.1055/s-2002-25141
Practical Aspect of Intervention in Vascular Anomalies in Children
Further Information
Publication History
Publication Date:
17 April 2002 (online)
ABSTRACT
The authors describe the treatment of various vascular anomalies in children. Vascular tumors such as hemangiomas and angiosarcomas are discussed. Vascular malformations such as lymphatic malformations, arteriovenous malformations, and various venous abnormalities are detailed.
KEYWORD
Vascular malformations - catheter angiography - pediatric angiography
REFERENCES
- 1 Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med . 1995; 333 1757-1763
- 2 Takabashi K, Mulliken J B, Kozakewich H, Rogers R A, Folkman J, Ezekowitz R A. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest . 1994; 93 2357-2364
- 3 Vikkula M, Boon L M, Mulliken J B, Olsew B R. Molecular basis of vascular anomalies. Trends Cardiovasc Med . 1998; 8 281-292
- 4 Mulliken J B, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg . 1982; 69 412-422
- 5 Enjolras O, Mulliken J B. Vascular tumors and vascular malformations (new issues). Adv Dermatol . 1998; 13 375-423
- 6 Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol . 1997; 24 701-710
- 7 Glowacki J, Mulliken J B. Mast cells in hemangiomas and vascular malformations. Pediatrics . 1982; 70 48-51
- 8 Pollman M J, Naumovski L, Gibbons G H. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-β1 on endothelial cells versus smooth muscle cells. Circulation . 1999; 99 2019-2026
- 9 Razon M J, Kraling B M, Mulliken J B, Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation . 1998; 5 189-195
- 10 Arbiser J L. Angiogenesis and the skin: a primer. J Am Acad Dermatol . 1996; 34 486-497
- 11 Enjolras O. Vascular tumors and vascular malformations: are we at the dawn of a better knowledge?. Pediatr Dermatol . 1999; 16 238-241
- 12 Enjolras O, Gelbert F. Superficial hemangiomas: associations and management. Pediatr Dermatol . 1997; 14 173-179
- 13 Frieden I J, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol . 1996; 132 307-311
- 14 Sarkar M, Mulliken J B, Kozakewich H PW. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg . 1997; 100 1377-1386
- 15 Enjolras O, Wassef M, Mazoyer E. Infants with Kasabach-Merritt syndrome do not have ``true hemangiomas''. J Pediatr . 1997; 130 631-640
- 16 Daller J A, Bueno J, Gutierrez J. Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg . 1999; 34 98-106
- 17 Enjolras O, Mulliken J B, Wassef M. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol . 2000; 42 225-235
- 18 Selby D M, Stocker J T, Ishak K G. Angiosarcoma of the liver in childhood: a clinicopathologic and follow-up study of 10 cases. Pediatr Pathol . 1992; 12 485-498
- 19 Awan S, Davenport M, Portmann B. Angiosarcoma of the liver in children. J Pediatr Surg . 1996; 31 1729-1732
- 20 Boon L M, Brouillard P, Irrthum A. A gene for inherited cutaneous venous anomalies (``glomangiomas'') localizes to chromosome 1p21-22. Am J Hum Genet . 1999; 65 125-133
- 21 Blei F, Walter J, Orlow S J. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol . 1998; 134 718-722
- 22 Enjolras O, Ciabrini D, Mazoyer E, Lauriane C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol . 1997; 36 219-225
- 23 Gallagher P G, Mahoney M J, Gosche J R. Cystic hygroma in the fetus and newborn. Semin Perinatol . 1999; 23 341-356
- 24 Dubois J, Patriquin H B, Garel L. Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR Am J Roentgenol . 1998; 171 247-252
- 25 Dubois J, Garel L, Grignon A. Imaging of hemangiomas and vascular malformations in children. Acad Radiol . 1998; 5 390-400
- 26 Burrows P E, Laor T, Paltiel H. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin . 1998; 16 455-488
- 27 Barnes P D, Burrows P E, Hoffer F A, Mulliken J B. Hemangiomas and vascular malformations of the head and neck: MR characterization [letter]. AJNR Am J Neuroradiol . 1994; 15 193-195
- 28 Baker L L, Dillon W P, Hieshima G B. Hemangiomas and vascular malformations of the head and neck: MR characterization. AJNR Am J Neuroradiol . 1993; 14 307-314
- 29 Huston III J, Forbes G S, Ruefenacht D A. Magnetic resonance imaging of facial vascular anomalies. Mayo Clin Proc . 1992; 67 739-747
- 30 Hoffer F A. Facial vascular anomalies: clarity with magnetic resonance imaging and biologic classification. Mayo Clin Proc . 1992; 67 807-809
- 31 Frieden I J. Management of hemangiomas. Special symposium. Pediatr Dermatol . 1997; 14 57-83
- 32 Mulliken J B, Boon L M, Takahashi K. Pharmacologic therapy for endangering hemangiomas. Curr Opin Dermatol . 1995; 2 109-113
- 33 Drolet B A, Esterly N B, Frieden I J. Hemangiomas in children. Prim Care . 1999; 341 173-181
- 34 Ezekowitz R A, Mulliken J B, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med . 1992; 326 1456-1463
- 35 Barlow C F, Priebe C J, Mulliken J B. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr . 1998; 132 527-530
- 36 Dubois J, Hershon L, Carmant L, Bélanger S, Leclerc J M, David M. Toxicity profile of interferon alfa-2b in children: a prospective evaluation. J Pediatr . 1999; 135 782-785
- 37 Burrows P E. Variations in the vascular supply to infantile hepatic hemangioendotheliomas. Radiology . 1991; 181 631-632
- 38 Upton J, Coombs C J, Mulliken J B, Burrows P E, Pap S. Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg [Am] . 1999; 24 1019-1035
- 39 Yakes W F, Luethke J M, Parker S H. Ethanol embolization of vascular malformations. Radiographics . 1990; 19 787-796
- 40 Dubois J, Sebag G H, De Prost Y, Teillac D, Chrétien B, Brunelle F. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc. Radiology . 1991; 180 195-198
- 41 DeLorimier A A. Sclerotherapy for venous malformations. J Pediatr Surg . 1995; 30 188-194
- 42 Berenguer B, Burrows P E, Zurakowski D, Mulliken J B. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg . 1999; 104 1-11
- 43 O'Donovan J C, Donaldson J S, Morello F P, Pensler J M, Vogelzang R L, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol . 1997; 169 723-729
- 44 Siniluoto T M, Svendsen P A, Wikholm G M, Fogdestam I, Edstrom S. Percutaneous sclerotherapy of venous malformations in the head and neck using sodium tetradecyl sulphate (Sotradecol). Scand J Plast Reconstr Surg Hand Surg . 1997; 31 145-150
- 45 Hancock B J, St-Vil D, Di Lorenzo M, Blanchard H. Complications of lymphangiomas in children. Pediatr Surg . 1992; 27 220-226
- 46 Dickerhoff R, Bode V U. Cyclophosphamide in non-resectable cystic hygroma. Lancet . 1990; 335 1474-1475
- 47 Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg . 1995; 30 1282-1287
- 48 Okada A, Kubota A, Fukyzama M. Injection of bleomycin as a primary therapy of cystic lymphangioma. J Pediatr Surg . 1992; 27 440-443
- 49 Mikhail M, Kennedy R, Cramer B, Smith T. Sclerosing of recurrent lymphangioma using OK-432. J Pediatr Surg . 1995; 30 1159-1160
- 50 Ogita S, Tsuto T, Nakamura K. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg . 1994; 29 784-785
- 51 Farmand M, Kuttenberger J J. A new therapeutic concept for the treatment of cystic hygroma. Oral Surg Oral Med Oral Pathol . 1995; 81 389-395
- 52 Dubois J, Garel L, Abela A. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology . 1997; 204 651-654
- 53 Castanon M, Margarit J, Carrasco R, Vancells M, Albert A, Morales L. Long-term follow-up of nineteen cystic lymphangiomas treated with fibrin sealant. J Pediatr Surg . 1999; 34 1276-1279.
- 54 Gutierrez San Roman C, Barrios J, Lluna J. Treatment of cervical lymphangioma using fibrin adhesive. Eur J Pediatr Surg . 1993; 3 356-358
- 55 Greinwald J H, Burke D K, Sato Y. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg . 1999; 121 381-387
- 56 Herbreteau D, Riche M C, Enjolras O. Percutaneous embolization with Ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients. Int Angiol . 1993; 12 34-49
- 57 Han M H, Seong S O, Kim H D, Chang K H, Yeon K M, Han M C. Craniofacial arteriovenous malformation: preoperative embolization with direct puncture and injection of n-butyl cyanoacrylate. Radiology . 1999; 211 661-666
- 58 Kohout M P, Hansen M, Pribaz J J, Mulliken J B. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg . 1998; 102 643-654
- 59 Beek F J, ten Broek W F, van Schaik P J, Mali W P. Transvenous embolisation of an arteriovenous malformation of the mandible via a femoral approach. Pediatr Radiol . 1997; 27 855-857
- 60 Yakes W F, Rossi P, Odink H. How I do it: arteriovenous malformation management. Cardiovasc Intervent Radiol . 1996; 19 65-71
- 61 Yakes W F, Krauth L, Ecklund J. Ethanol endovascular management of brain arteriovenous malformations: initial results. Neurosurgery. . 1997; 40 1145-1154
- 62 Yakes W F, Luethke J M, Merland J J. Ethanol embolization of arteriovenous fistulas: a primary mode of therapy. J Vasc Interv Radiol . 1990; 1 89-96
- 63 Behnia R. Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity. Anesth Analg . 1995; 80 415-417
- 64 Chen M T, Horng S Y, Yeong E K, Pan Q D. Treatment of high-flow vascular malformations in the head and neck with arterial ligation followed by sclerotherapy. Ann Plast Surg . 1996; 36 147
- 65 Svendsen P A, Wikholm G, Fogdestam I, Anniko M, Mendel L. Direct puncture of large arteriovenous malformations in head and neck for embolization and subsequent reconstructive surgery. Scand J Plast Reconstr Surg Hand Surg . 1994; 28 131
- 66 Coldwell D M, Stokes K R, Yakes W F. Embolotherapy: agents, clinical applications, and techniques. Radiographics . 1994; 14 623-643
- 67 Dubois J. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol . 1999; 29 879-893